Your Trusted Brand for Over 35 Years

Hypoglycemia References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. BraunwaldDE , Kasper DL, et al, eds. Harrison 's Principles of Internal Medicine. New York: McGraw-Hill; 2001:2138–43.
  2. Barzilai N. Disorders of carbohydrate metabolism. In: Beers MH, Berkow R, eds. The Merck Manual of Diagnosis and Therapy.Rahway , NJ : Merck Research Laboratories; 1999.
  3. Kasper DL, BraunwaldDE , et al. Harrison's Principles of Internal Medicine . 16th ed. New York: McGraw-Hill Professional; 2005.
  4. Johnson SF, Schade DS, et al. Chlorpropamide-induced hypoglycemia: Successful treatment with diazoxide. Am J Med. 1977 Nov;63(5):799–804.
  5. Pfeifer MA, Wolter CF, et al. Management of chlorpropamide-induced hypoglycemia with diazoxide.South Med J. 1978 May;71(5):606–8.
  6. Winegrad A. Disorders of carbohydrate metabolism. In: Berkow RB, Fletcher AJ, Beers MK, eds. The Merck Manual of Diagnosis and Therapy.Rahway , NJ: Merck Research Laboratories; 1992:1126–32.
  7. Racek J. Chromium as an essential element.CasLekCesk. 2003;142(6):335–9.
  8. McCarty MF. Chromium and other insulin sensitizers may enhance glucagon secretion: Implications for hypoglycemia and weight control. Med Hypotheses. 1996 Feb;46(2):77–80. Review.
  9. Stumvoll M, Perriello G, et al. Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int. 1999;55(3):778.
  10. Nair KS, Welle SL, et al. Effect of plasma amino acid replacement on glucagon and substrate responses to insulin-induced hypoglycemia in humans.Diabetes. 1990;39(3):376–82.
  11. Caprio C, Tamborlane WV, et al. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.Diabetes. 1993;42(4):550–5.
  12. de Souza HM, Borba-Murad GR, et al. Rat liver responsiveness to gluconeogenic substrates during insulin-induced hypoglycemia. Braz J Med Biol Res. 2001 Jun;34(6):771–7.
  13. Sprague CL, Elfarra AA. Protection of rats against 3-butene-1,2-diol-induced hepatoxicity and hypoglycemia by N-acetylcysteine. ToxicolApplPharmacol. 2005 Sep 15;207(3):266–74.
  14. Pal S, ChatterjeeAK .Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate.Drug ChemToxicol. 2004 May;27(2):179–80.